1. Home
  2. BJDX vs PBM Comparison

BJDX vs PBM Comparison

Compare BJDX & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BJDX
  • PBM
  • Stock Information
  • Founded
  • BJDX 2015
  • PBM 1994
  • Country
  • BJDX United States
  • PBM Canada
  • Employees
  • BJDX N/A
  • PBM N/A
  • Industry
  • BJDX Medical Specialities
  • PBM
  • Sector
  • BJDX Health Care
  • PBM
  • Exchange
  • BJDX Nasdaq
  • PBM NYSE
  • Market Cap
  • BJDX 2.9M
  • PBM 3.0M
  • IPO Year
  • BJDX 2021
  • PBM N/A
  • Fundamental
  • Price
  • BJDX $1.58
  • PBM $4.91
  • Analyst Decision
  • BJDX
  • PBM
  • Analyst Count
  • BJDX 0
  • PBM 0
  • Target Price
  • BJDX N/A
  • PBM N/A
  • AVG Volume (30 Days)
  • BJDX 2.1M
  • PBM 114.1K
  • Earning Date
  • BJDX 08-13-2025
  • PBM 07-07-2025
  • Dividend Yield
  • BJDX N/A
  • PBM N/A
  • EPS Growth
  • BJDX N/A
  • PBM N/A
  • EPS
  • BJDX N/A
  • PBM 5.24
  • Revenue
  • BJDX N/A
  • PBM N/A
  • Revenue This Year
  • BJDX N/A
  • PBM N/A
  • Revenue Next Year
  • BJDX $55.56
  • PBM N/A
  • P/E Ratio
  • BJDX N/A
  • PBM $0.94
  • Revenue Growth
  • BJDX N/A
  • PBM N/A
  • 52 Week Low
  • BJDX $1.46
  • PBM $2.93
  • 52 Week High
  • BJDX $44.50
  • PBM $701.82
  • Technical
  • Relative Strength Index (RSI)
  • BJDX 42.16
  • PBM 53.67
  • Support Level
  • BJDX $1.49
  • PBM $4.52
  • Resistance Level
  • BJDX $1.63
  • PBM $5.23
  • Average True Range (ATR)
  • BJDX 0.16
  • PBM 0.54
  • MACD
  • BJDX -0.00
  • PBM -0.01
  • Stochastic Oscillator
  • BJDX 7.29
  • PBM 49.93

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: